CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 101 enrolled
Drug / intervention
Sufentanil NanoTab 20 mcg +2 moredrug
Likely dose
Sufentanil NanoTab 20 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01710345
NCT01710345Phase 2Completed
CompareCT.gov

Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy

Talphera, Inc·interventional·Posted Oct 19, 2012·Updated Jan 26, 2015

In Brief

A Phase 2 clinical trial evaluating Sufentanil NanoTab 20 mcg, Sufentanil NanoTab 30 mcg, and 1 other intervention for Acute Pain. Completed, enrolled 101 participants across 2 sites.

Detailed Summary

This is a dose-finding study to determine if the sublingual administration of the Sufentanil NanoTab is safe and effective in the treatment of post-operative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 19, 2012
Enrollment StartOct 1, 2012
Primary CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 13.7 years ago

Interventions

Sufentanil NanoTab 20 mcgdrug

Sufentanil NanoTab 30 mcgdrug

Placebo NanoTabdrug